Article: Dr. Reddy's Laboratories Limited Announce Agreement for Utilizing Incyte LifeSeq(R) Gold Online.

LifeSeq(R) Gold to Further Advance Dr. Reddy's Research and Development

Programs in Cancer, Diabetes, Infectious Diseases and Pain Therapeutic

Development Through Genomics

PALO ALTO, Calif., HYDERABAD, India and ATLANTA, Nov. 20 /PRNewswire/ --

Dr. Reddy's Laboratories Limited (NYSE: RDY), an emerging global pharmaceutical company, and Reddy US Therapeutics, Inc. ("Reddy US"), a wholly-owned subsidiary of Dr. Reddy's, and Incyte Genomics, Inc. (Nasdaq: INCY), the leading genomic information company, today announced the signing of a collaborative agreement allowing Dr. Reddy's and Reddy US access to LifeSeq(R) Gold, Incyte's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!